| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SWTX | Common Stock | Sale | -$31.5K | -371 | -0.01% | $84.90 | 6.19M | Jun 7, 2021 | See Footnotes | F1, F2, F3 |
| transaction | SWTX | Common Stock | Sale | -$3.64M | -42.6K | -0.69% | $85.37 | 6.14M | Jun 8, 2021 | See Footnotes | F2, F3, F4 |
| transaction | SWTX | Common Stock | Sale | -$431K | -5.05K | -0.08% | $85.33 | 6.14M | Jun 9, 2021 | See Footnotes | F2, F3, F5 |
| Id | Content |
|---|---|
| F1 | These shares of the Issuer's common stock were sold in a block order at a price of $84.90 pursuant to a Rule 10b5-1 trading plan established by OrbiMed Private Investments VI, LP ("OPI VI"). |
| F2 | These shares of the Issuer's common stock are held of record by OPI VI. OrbiMed Capital GP VI LLC ("OrbiMed GP VI") is the general partner of OPI VI, and OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment adviser under the Investment Advisors Act of 1940, as amended, is the managing member of OrbiMed GP VI. By virtue of such relationships, OrbiMed GP VI and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI VI noted above and, as a result, may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI. |
| F3 | This report is being jointly filed by OrbiMed Advisors and OrbiMed GP VI. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. |
| F4 | These shares of the Issuer's common stock were sold in a block order at a price of $85.37 pursuant to a Rule 10b5-1 trading plan established by OPI VI. |
| F5 | These shares of the Issuer's common stock were sold in a block order at a price of $85.33 pursuant to a Rule 10b5-1 trading plan established by OPI VI. |